Dexcom Hit With Atty Fees For 'Bad Faith' Patent Suit

Diabetes glucose monitoring company Dexcom Inc. has to pay attorneys' fees to its New Hampshire-based rival after a California federal judge held that it acted in "bad faith" by continuing to...

Already a subscriber? Click here to view full article